Parkinson's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Parkinson's Disease, including details on symptoms, treatment, genetics, medication.

Volume 3 (2006), Issue 12 (December)

1. 3-Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited damage both in vivo and in vitro.
   FASEB J, 20(14): 2496-511. [Abstract] [Full-text]
2. Selective enrichment of DJ-1 protein in primate striatal neuronal processes: implications for Parkinson's disease.
   J Comp Neurol, 500(3): 585-99. [Abstract] [Full-text]
3. Patient-specific analysis of the volume of tissue activated during deep brain stimulation.
   Neuroimage, 34(2): 661-70. [Abstract] [Full-text]
4. Metabolic brain networks associated with cognitive function in Parkinson's disease.
   Neuroimage, 34(2): 714-23. [Abstract] [Full-text]
5. Recognition and management of neuropsychiatric complications in Parkinson's disease.
   CMAJ, 175(12): 1545-52. [Abstract] [Full-text]
6. Comprehensive association analysis of the NOS2A gene with Parkinson disease.
   Neurology, 67(11): 2080-2. [Abstract] [Full-text]
7. Body mass index and the risk of Parkinson disease.
   Neurology, 67(11): 1955-9. [Abstract] [Full-text]
8. Differences in neuropathologic characteristics across the Lewy body dementia spectrum.
   Neurology, 67(11): 1931-4. [Abstract] [Full-text]
9. Characterizing rule-based category learning deficits in patients with Parkinson's disease.
   Neuropsychologia, 45(2): 305-20. [Abstract] [Full-text]
10. Impaired self-initiated task preparation during task switching in Parkinson's disease.
    Neuropsychologia, 45(2): 273-81. [Abstract] [Full-text]
11. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Neuropsychologia, 45(2): 357-67. [Abstract] [Full-text]
12. PINK1 mutation heterozygosity and the risk of Parkinson's disease.
    J Neurol Neurosurg Psychiatry, 78(1): 82-4. [Abstract] [Full-text]
13. Abnormal susceptibility to distracters hinders perception in early stage Parkinson's disease: a controlled study.
    BMC Neurol, 6: 43. [Abstract] [Full-text]
14. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress.
    J Neurol Neurosurg Psychiatry, 78(1): 36-42. [Abstract] [Full-text]
15. Non-invasive imaging of neuropathology in a rat model of alpha-synuclein overexpression.
    Neurobiol Aging, 28(2): 248-57. [Abstract] [Full-text]
16. Motor responses of muscles supplied by cranial nerves to subthalamic nucleus deep brain stimuli.
    Brain, 130: 245-55. [Abstract] [Full-text]
17. Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism.
    Brain, 130: 265-75. [Abstract] [Full-text]
18. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Brain, 130: 222-32. [Abstract] [Full-text]
19. Cortical activity in Parkinson's disease during executive processing depends on striatal involvement.
    Brain, 130: 233-44. [Abstract] [Full-text]
20. Early abnormalities of vascular and cardiac autonomic control in Parkinson's disease without orthostatic hypotension.
    Hypertension, 49(1): 120-6. [Abstract] [Full-text]
21. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(1): 311-3. [Abstract] [Full-text]
22. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder.
    Neurology, 67(12): 2236-8. [Abstract] [Full-text]
23. Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI.
    Neurology, 67(12): 2199-205. [Abstract] [Full-text]

© 2004-2008 Parkinson's Disease Research Today. All Rights Reserved.